Bispecific antibody-derived molecules to target persistent HIV infection

HIV infection persists despite durable and potent antiviral therapy. To target persistent HIV infection, one major strategy aims to induce HIV provirus expression using latency reversing agents and then eliminate these reservoir cells via immune responses enhanced by treatment with antibody-derived...

Descripción completa

Detalles Bibliográficos
Autores principales: Nordstrom, Jeffrey L., Ferrari, Guido, Margolis, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468498/
https://www.ncbi.nlm.nih.gov/pubmed/36111287
http://dx.doi.org/10.1016/j.jve.2022.100083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468498/
https://www.ncbi.nlm.nih.gov/pubmed/36111287
http://dx.doi.org/10.1016/j.jve.2022.100083

Ejemplares similares